This Policy Brief helps fill an important gap in our understanding of medication patterns in long-term care facilities (LTCFs) by comparing use and spending for prescription and over-the-counter drugs during skilled nursing facility (SNF) stays and related non-qualifying long-term care facility episodes.
Prescription Drugs
Reports
Displaying 81 - 90 of 103. 10 per page. Page 9.
Advanced SearchAnalysis of Supply, Distribution, Demand, and Access Issues Associated with Immune Globulin Intravenous (IGIV)
Contents IGIV Supply and Distribution - Key Findings IGIV Demand - Key Fundings IGIV Access Problems- Key Fundings Immune globulin intravenous (IGIV), also referred to as intravenous immune globulin (IVIG), is a valuable treatment for many seriously ill patients. Although the U.S.
Report
An Overview of the US Health System Chart Book
Report authors : George Greenberg, Nancy DeLew Office of the Assistant Secretary for Planning and Evaluation (ASPE) U.S. Department of Health and Human Services
National Estimates of Prescription Drug Utilization and Expenditures in Long-Term Care Facilities
This Policy Brief offers an updated look at prescription drug utilization by Medicare beneficiaries residing in long-term care facilities and reports, for the first time, national estimates of prescription drug spending by this population. [23 PDF pages]
Geographic Variation in Prescription Drug Prices and Spending
This paper examines by state variation in drug prices and drug spending. Variation in prices are found to be minimal but variation in spending (and utilization) are more substantial. Further work will explore the underlying reasons for the spending variation and whether patterns persist when analyzed for areas other than states.
Developing A Risk Adjustment Methodology for Medicare Drug Plans
This paper describes the work NORC did to supplement the Federal Employee Health Benefits data (FEHBP) used to develop drug risk adjustment factors for over 65 individuals with a full drug supplement to Medicare. This data needed to be supplemented because the FEHBP data did not adequately represent, low-income, disabled, or non east Coast populations.
Issues in the Design and Implementation of Drug Formularies and Therapeutic Classes
As part of the Medicare Part D pharmacy benefit scheduled for implementation in 2006 by the Medicare Prescription Drug, Improvement, and Modernization Act (MMA), beneficiaries will have a choice of private plans administering the benefit.? Although plans are required to provide access to needed drugs, the law does not require plans to provide equal coverage for all drugs.?